The human innovation company Brighter engaged Veryday in the development of Actiste – a next-generation medical device that will drive behavioral change and improve the lives of people with diabetes.
By combining three essential components of everyday diabetes management (a blood glucose meter, a lancet and an injection pen) into a single device, Brighter offers the user simpler, faster and more accurate treatment than ever before. Thanks to the integration of all necessary functions into one device, the number of steps in daily diabetes treatment is reduced by up to 67 %.
Actiste allows the user to log the exact volume of insulin injected, measure blood sugar, log meals and other events, and share their data through a connected service. Knowing when and how much insulin has been injected is critical for quality of self-care, and important for family members and other caregivers to know. Through Actiste’s mobile connected service, users and caregivers can easily track blood sugar levels and insulin dose history on any smartphone or browser. This increases the user’s self-care motivation and quality of life while also providing the correct information for optimal treatment.